Is It Time To Reassess Collegium Pharmaceutical (COLL) After Its Strong Five Year Share Price Run? [Yahoo! Finance]
Collegium Pharmaceutical, Inc. (COLL)
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.collegiumpharma.com
Company Research
Source: Yahoo! Finance
The stock last closed at US$45.54, with returns of 0.0% over 7 days, a 6.8% decline over 30 days, and gains of 38.4% over 1 year, 58.5% over 3 years, and 89.3% over 5 years, which can influence how you think about both upside and risk today. Recent coverage of Collegium has focused on its role in the US pharmaceutical and biotech market and ongoing attention from investors assessing prescription pain management businesses, which has kept interest in the stock alive. This context helps explain why the longer term performance figures are front of mind for many shareholders even when shorter term movements are flat or negative. On our valuation checklist, Collegium scores 2 out of 6 , so we will look at how different methods such as cash flow based models and multiples compare, then finish with a simple way to bring these valuation signals together. Collegium Pharmaceutical scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown
Show less
Read more
Impact Snapshot
Event Time:
COLL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COLL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COLL alerts
High impacting Collegium Pharmaceutical, Inc. news events
Weekly update
A roundup of the hottest topics
COLL
News
- Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual ConferenceGlobeNewswire
- Collegium Pharmaceutical EVP Sells COLL 17,600 Shares Amid Strong Close of 2025 [Yahoo! Finance]Yahoo! Finance
- Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? [Yahoo! Finance]Yahoo! Finance
- Will Authorized Generic Nucynta Launch and New Credit Facility Change Collegium Pharmaceutical's (COLL) Narrative? [Yahoo! Finance]Yahoo! Finance
- Collegium Pharmaceutical (NASDAQ:COLL) had its price target lowered by analysts at Barclays PLC from $58.00 to $56.00. They now have an "overweight" rating on the stock.MarketBeat
COLL
Earnings
- 11/6/25 - Beat
COLL
Sec Filings
- 1/8/26 - Form 8-K
- 12/30/25 - Form 8-K
- 12/17/25 - Form 144
- COLL's page on the SEC website